Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Asia-Pacific Radiotherapy Market - Industry Trends and Forecast To 2027

Published by Data Bridge Market Research Private Limited Product code 961960
Published Content info 140 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia-Pacific Radiotherapy Market - Industry Trends and Forecast To 2027
Published: August 1, 2020 Content info: 140 Pages
Description

Asia-Pacific radiotherapy market is projected to register a CAGR of 6.4% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Asia-Pacific Radiotherapy Market By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/Radiopharmaceuticals & Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software & Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer & Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics & Others), Distribution Channel (Direct Tender, Retail Sales & Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines & Rest of Asia-Pacific) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Asia-Pacific radiotherapy market are:

Use of radiotherapy treatment in wide cancer applications

Technology advance in radiotherapy products

Market Players:

The key market players for Asia-Pacific radiotherapy market are listed below:

Varian Medical Systems, Inc.

Mevion Medical Systems

VIEWRAY TECHNOLOGIES, INC. (A Subsidiary of ViewRay)

Siemens Healthcare GmbH

Elekta AB

Accuray Incorporated

IBA Worldwide

Eckert & Ziegler BEBIG

RaySearch Laboratories

Brainlab AG

Koninklijke Philips N.V.

GE Healthcare

Hitachi, Ltd.

Nordion (Canada) Inc.

Sumitomo Heavy Industries, Ltd.

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF ASIA-PACIFIC RADIOTHERAPY MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 TYPE LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ASIA-PACIFIC RADIOTHERAPY MARKET, MARKET SHARE ANALYSIS
    • 4.1.1 MARKET SHARE ANALYSIS: ASIA-PACIFIC
    • 4.1.2 MARKET SHARE ANALYSIS: NORTH AMERICA
      • 4.1.2.1 MARKET SHARE ANALYSIS: U.S.
      • 4.1.2.2 MARKET SHARE ANALYSIS: CANADA
      • 4.1.2.3 MARKET SHARE ANALYSIS: MEXICO
    • 4.1.3 MARKET SHARE ANALYSIS: EUROPE
      • 4.1.3.1 MARKET SHARE ANALYSIS: GERMANY
      • 4.1.3.2 MARKET SHARE ANALYSIS: FRANCE
      • 4.1.3.3 MARKET SHARE ANALYSIS: ITALY
      • 4.1.3.4 MARKET SHARE ANALYSIS: U.K.
      • 4.1.3.5 MARKET SHARE ANALYSIS: SPAIN
      • 4.1.3.6 MARKET SHARE ANALYSIS: RUSSIA
      • 4.1.3.7 MARKET SHARE ANALYSIS: NETHERLANDS
      • 4.1.3.8 MARKET SHARE ANALYSIS: SWITZERLAND
      • 4.1.3.9 MARKET SHARE ANALYSIS: BELGIUM
      • 4.1.3.10 MARKET SHARE ANALYSIS: TURKEY
      • 4.1.3.11 MARKET SHARE ANALYSIS: UKRAINE
    • 4.1.4 MARKET SHARE ANALYSIS: ASIA-PACIFIC
      • 4.1.4.1 MARKET SHARE ANALYSIS: CHINA
      • 4.1.4.2 MARKET SHARE ANALYSIS: JAPAN
      • 4.1.4.3 MARKET SHARE ANALYSIS: INDIA
      • 4.1.4.4 MARKET SHARE ANALYSIS: AUSTRALIA
      • 4.1.4.5 MARKET SHARE ANALYSIS: SOUTH KOREA
      • 4.1.4.6 MARKET SHARE ANALYSIS: INDONESIA
      • 4.1.4.7 MARKET SHARE ANALYSIS: THAILAND
      • 4.1.4.8 MARKET SHARE ANALYSIS: SINGAPORE
      • 4.1.4.9 MARKET SHARE ANALYSIS: MALAYSIA
      • 4.1.4.10 MARKET SHARE ANALYSIS: PHILIPPINES
    • 4.1.5 MARKET SHARE ANALYSIS: SOUTH AMERICA
      • 4.1.5.1 MARKET SHARE ANALYSIS: BRAZIL
      • 4.1.5.2 MARKET SHARE ANALYSIS: ARGENTINA
      • 4.1.5.3 MARKET SHARE ANALYSIS: CHILE
    • 4.1.6 MARKET SHARE ANALYSIS: MIDDLE EAST AND AFRICA
      • 4.1.6.1 MARKET SHARE ANALYSIS: SOUTH AFRICA
      • 4.1.6.2 MARKET SHARE ANALYSIS: SAUDI ARABIA
      • 4.1.6.3 MARKET SHARE ANALYSIS: UAE
      • 4.1.6.4 MARKET SHARE ANALYSIS: EGYPT
      • 4.1.6.5 MARKET SHARE ANALYSIS: ISRAEL
  • 4.2 ASIA-PACIFIC PROTON BEAM THERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.2.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
    • 4.2.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.2.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.2.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.2.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.2.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.2.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.2.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.2.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.2.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.2.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.2.4.1 company share analysis: CHINA
      • 4.2.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.2.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.2.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.3 ASIA-PACIFIC BRACHYTHERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.3.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
    • 4.3.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.3.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.3.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.3.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.3.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.3.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.3.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.3.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.3.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.3.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.3.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.3.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.3.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.3.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.4 ASIA-PACIFIC IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.4.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
    • 4.4.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.4.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.4.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.4.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.4.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.4.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.4.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.4.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.4.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.4.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.4.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.4.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.4.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.4.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.5 ASIA-PACIFIC STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.5.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
    • 4.5.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.5.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.5.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.5.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.5.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.5.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.5.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.5.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.5.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.5.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.5.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.5.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.5.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.5.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA

5 IMPACT OF COVID-19 ON ASIA-PACIFIC RADIOTHERAPY MARKET

  • 5.1 IMPACT ANALYSIS ON DEMAND
  • 5.2 CONCLUSION

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 GROWING PREVALENCE OF CANCER DISEASE
    • 6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT
    • 6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
    • 6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
  • 6.2 RESTRAINTS
    • 6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    • 6.2.2 COMPLEX NATURE OF RADIOTHERAPY
    • 6.2.3 HIGH COST OF RADIOTHERAPY PROCEDURES
  • 6.3 OPPORTUNITIES
    • 6.3.1 INCREASING HEALTHCARE EXPENDITURES FOR CANCER TREATMENTS
    • 6.3.2 GROWING GOVERNMENT INITIATIVES TOWARDS CANCER TREATMENT
    • 6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
  • 6.4 CHALLENGES
    • 6.4.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
    • 6.4.2 RISK OF RADIATION EXPOSURE

7 ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE

  • 7.1 OVERVIEW
  • 7.2 EXTERNAL-BEAM RADIATION THERAPY
    • 7.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
    • 7.2.2 PROTON BEAM THERAPY
    • 7.2.3 STEREOTACTIC RADIATION THERAPY
    • 7.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)
    • 7.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)
    • 7.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
    • 7.2.7 OTHERS
  • 7.3 INTERNAL RADIATION THERAPY
    • 7.3.1 BRACHYTHERAPY
    • 7.3.2 SELECTIVE INTERNAL RADIATION THERAPY (SIRT)
    • 7.3.3 BRACHYTHERAPY
      • 7.3.3.1 HIGH DOSE BRACHYTHERAPY
      • 7.3.3.2 LOW DOSE BRACHYTHERAPY
  • 7.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
  • 7.5 OTHERS

8 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT

  • 8.1 OVERVIEW
  • 8.2 EXTERNAL BEAM RADIOTHERAPY
    • 8.2.1 LINAC
    • 8.2.2 PROTON THERAPY
    • 8.2.3 CYBER KNIFE
    • 8.2.4 GAMMA KNIFE
    • 8.2.5 OTHERS
  • 8.3 INTERNAL RADIOTHERAPY PRODUCTS
    • 8.3.1 SEEDS
    • 8.3.2 AFTERLOADERS
    • 8.3.3 OTHERS
  • 8.4 RADIOTHERAPY SOFTWARE
    • 8.4.1 IMAGE GUIDING SOFTWARE
    • 8.4.2 TREATMENT PLANNING SOFTWARE
    • 8.4.3 PATIENT POSITIONING SOFTWARE
    • 8.4.4 DOSAGE PLANNING SOFTWARE
    • 8.4.5 OTHERS

9 ASIA-PACIFIC RADIOTHERAPY MARKET, BY APPLICATION

  • 9.1 OVERVIEW
  • 9.2 BREAST CANCER
  • 9.3 LUNG CANCER
  • 9.4 PROSTATE CANCER
  • 9.5 COLORECTAL CANCER
  • 9.6 LYMPHOMA
  • 9.7 LIVER CANCER
  • 9.8 THYROID CANCER
  • 9.9 BRAIN CANCER
  • 9.10 CERVICAL CANCER
  • 9.11 SPINE CANCER
  • 9.12 OTHERS

10 ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER

  • 10.1 OVERVIEW
  • 10.2 HOSPITALS
  • 10.3 RADIATION THERAPY CENTERS
  • 10.4 SPECIALTY CLINICS
  • 10.5 OTHERS

11 ASIA-PACIFIC RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL

  • 11.1 OVERVIEW
  • 11.2 DIRECT TENDER
  • 11.3 RETAIL SALES
  • 11.4 OTHERS

12 ASIA-PACIFIC RADIOTHERAPY MARKET, BY GEOGRAPHY

  • 12.1 ASIA-PACIFIC
    • 12.1.1 CHINA
    • 12.1.2 JAPAN
    • 12.1.3 INDIA
    • 12.1.4 AUSTRALIA
    • 12.1.5 SOUTH KOREA
    • 12.1.6 INDONESIA
    • 12.1.7 THAILAND
    • 12.1.8 SINGAPORE
    • 12.1.9 MALAYSIA
    • 12.1.10 PHILIPPINES
    • 12.1.11 REST OF ASIA-PACIFIC

13 ASIA-PACIFIC RADIOTHERAPY MARKET, COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14 SWOT ANALYSIS

15 COMPANY PROFILE

  • 15.1 VARIAN MEDICAL SYSTEMS, INC.
    • 15.1.1 COMPANY SNAPSHOT
    • 15.1.2 REVENUE ANALYSIS
    • 15.1.3 COMPANY SHARE ANALYSIS
    • 15.1.4 PRODUCT PORTFOLIO
    • 15.1.5 RECENT DEVELOPMENTS
  • 15.2 ELEKTA AB
    • 15.2.1 COMPANY SNAPSHOT
    • 15.2.2 REVENUE ANALYSIS
    • 15.2.3 COMPANY SHARE ANALYSIS
    • 15.2.4 PRODUCT PORTFOLIO
    • 15.2.5 RECENT DEVELOPMENTS
  • 15.3 SIEMENS HEALTHCARE GMBH
    • 15.3.1 COMPANY SNAPSHOT
    • 15.3.2 REVENUE ANALYSIS
    • 15.3.3 COMPANY SHARE ANALYSIS
    • 15.3.4 PRODUCT PORTFOLIO
    • 15.3.5 RECENT DEVELOPMENTS
  • 15.4 GE HEALTHCARE
    • 15.4.1 COMPANY SNAPSHOT
    • 15.4.2 REVENUE ANALYSIS
    • 15.4.3 COMPANY SHARE ANALYSIS
    • 15.4.4 PRODUCT PORTFOLIO
    • 15.4.5 RECENT DEVELOPMENT
  • 15.5 ACCURAY INCORPORATED
    • 15.5.1 COMPANY SNAPSHOT
    • 15.5.2 REVENUE ANALYSIS
    • 15.5.3 COMPANY SHARE ANALYSIS
    • 15.5.4 PRODUCT PORTFOLIO
    • 15.5.5 RECENT DEVELOPMENT
  • 15.6 KONINKLIJKE PHILIPS N.V.
    • 15.6.1 COMPANY SNAPSHOT
    • 15.6.2 REVENUE ANALYSIS
    • 15.6.3 PRODUCT PORTFOLIO
    • 15.6.4 RECENT DEVELOPMENTS
  • 15.7 ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG)
    • 15.7.1 COMPANY SNAPSHOT
    • 15.7.2 REVENUE ANALYSIS
    • 15.7.3 PRODUCT PORTFOLIO
    • 15.7.4 RECENT DEVELOPMENT
  • 15.8 BRAINLAB AG
    • 15.8.1 COMPANY SNAPSHOT
    • 15.8.2 PRODUCT PORTFOLIO
    • 15.8.3 RECENT DEVELOPMENT
  • 15.9 CIVCO RADIOTHERAPY (A SUBSIDIARY OF ROPER TECHNOLOGIES, INC.)
    • 15.9.1 COMPANY SNAPSHOT
    • 15.9.2 REVENUE ANALYSIS
    • 15.9.3 PRODUCT PORTFOLIO
    • 15.9.4 RECENT DEVELOPMENT
  • 15.10 ECKERT & ZIEGLER BEBIG
    • 15.10.1 COMPANY SNAPSHOT
    • 15.10.2 REVENUE ANALYSIS
    • 15.10.3 PRODUCT PORTFOLIO
    • 15.10.4 RECENT DEVELOPMENT
  • 15.11 HITACHI, LTD.
    • 15.11.1 COMPANY SNAPSHOT
    • 15.11.2 REVENUE ANALYSIS
    • 15.11.3 PRODUCT PORTFOLIO
    • 15.11.4 RECENT DEVELOPMENT
  • 15.12 IBA WORLDWIDE
    • 15.12.1 COMPANY SNAPSHOT
    • 15.12.2 REVENUE ANALYSIS
    • 15.12.3 PRODUCT PORTFOLIO
    • 15.12.4 RECENT DEVELOPMENT
  • 15.13 ISORAY INC.
    • 15.13.1 COMPANY SNAPSHOT
    • 15.13.2 REVENUE ANALYSIS
    • 15.13.3 PRODUCT PORTFOLIO
    • 15.13.4 RECENT DEVELOPMENT
  • 15.14 MEVION MEDICAL SYSTEMS
    • 15.14.1 COMPANY SNAPSHOT
    • 15.14.2 PRODUCT PORTFOLIO
    • 15.14.3 RECENT DEVELOPMENT
  • 15.15 NORDION (CANADA) INC.
    • 15.15.1 COMPANY SNAPSHOT
    • 15.15.2 PRODUCT PORTFOLIO
    • 15.15.3 RECENT DEVELOPMENT
  • 15.16 PROTOM INTERNATIONAL
    • 15.16.1 COMPANY SNAPSHOT
    • 15.16.2 PRODUCT PORTFOLIO
    • 15.16.3 RECENT DEVELOPMENT
  • 15.17 PROVISION HEALTHCARE
    • 15.17.1 COMPANY SNAPSHOT
    • 15.17.2 SOLUTION PORTFOLIO
    • 15.17.3 RECENT DEVELOPMENT
  • 15.18 RAYSEARCH LABORATORIES
    • 15.18.1 COMPANY SNAPSHOT
    • 15.18.2 REVENUE ANALYSIS
    • 15.18.3 PRODUCT PORTFOLIO
    • 15.18.4 RECENT DEVELOPMENT
  • 15.19 SUMITOMO HEAVY INDUSTRIES, LTD.
    • 15.19.1 COMPANY SNAPSHOT
    • 15.19.2 REVENUE ANALYSIS
    • 15.19.3 PRODUCT PORTFOLIO
    • 15.19.4 RECENT DEVELOPMENT
  • 15.20 VIEWRAY TECHNOLOGIES, INC. (A SUBSIDIARY OF VIEWRAY)
    • 15.20.1 COMPANY SNAPSHOT
    • 15.20.2 REVENUE ANALYSIS
    • 15.20.3 PRODUCT PORTFOLIO
    • 15.20.4 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 ASIA-PACIFIC CANCER INCIDENCE (2018)
  • TABLE 2 ASIA-PACIFIC CANCER INCIDENCE (2018)
  • TABLE 3 ASIA-PACIFIC CANCER INCIDENCE (2018)
  • TABLE 4 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
  • TABLE 5 PRODUCT CLASSIFICATION
  • TABLE 6 ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 7 ASIA-PACIFIC EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 ASIA-PACIFIC EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 9 ASIA-PACIFIC INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10 ASIA-PACIFIC INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 11 ASIA-PACIFIC BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 12 ASIA-PACIFIC SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 ASIA-PACIFIC OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 15 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 16 ASIA-PACIFIC DEVICES IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 ASIA-PACIFIC EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 18 ASIA-PACIFIC INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19 ASIA-PACIFIC INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 20 ASIA-PACIFIC RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 21 ASIA-PACIFIC RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 22 ASIA-PACIFIC RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 23 ASIA-PACIFIC BREAST CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 24 ASIA-PACIFIC LUNG CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25 ASIA-PACIFIC PROSTATE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 26 ASIA-PACIFIC COLORECTAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 27 ASIA-PACIFIC LYMPHOMA IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 28 ASIA-PACIFIC LIVER CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 29 ASIA-PACIFIC THYROID CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 30 ASIA-PACIFIC BRAIN CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 31 ASIA-PACIFIC CERVICAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 32 ASIA-PACIFIC SPINE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 33 ASIA-PACIFIC OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 34 ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 35 ASIA-PACIFIC HOSPITALS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 36 ASIA-PACIFIC RADIATION THERAPY CENTERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 37 ASIA-PACIFIC SPECIALTY CLINICS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 38 ASIA-PACIFIC OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 39 ASIA-PACIFIC RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 40 ASIA-PACIFIC DIRECT TENDER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 41 ASIA-PACIFIC RETAIL SALES IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 42 ASIA-PACIFIC OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 43 ASIA-PACIFIC RADIOTHERAPY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 44 ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 ASIA-PACIFIC EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 46 ASIA-PACIFIC INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 47 ASIA-PACIFIC BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 48 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 49 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 50 ASIA-PACIFIC EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 51 ASIA-PACIFIC INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 52 ASIA-PACIFIC RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 53 ASIA-PACIFIC RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 54 ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 55 ASIA-PACIFIC RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 56 CHINA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 57 CHINA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 58 CHINA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 59 CHINA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 60 CHINA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 61 CHINA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 62 CHINA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 63 CHINA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 64 CHINA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 65 CHINA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 66 CHINA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 67 CHINA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 68 JAPAN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 69 JAPAN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 70 JAPAN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 71 JAPAN BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 72 JAPAN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 73 JAPAN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 74 JAPAN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 75 JAPAN INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 76 JAPAN RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 77 JAPAN RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 78 JAPAN RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 79 JAPAN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 80 INDIA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 81 INDIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 82 INDIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 83 INDIA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 84 INDIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 85 INDIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 86 INDIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 87 INDIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 88 INDIA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 89 INDIA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 90 INDIA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 91 INDIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 92 AUSTRALIA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 93 AUSTRALIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 94 AUSTRALIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 95 AUSTRALIA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 96 AUSTRALIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 97 AUSTRALIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 98 AUSTRALIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 99 AUSTRALIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 100 AUSTRALIA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 101 AUSTRALIA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 102 AUSTRALIA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 103 AUSTRALIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 104 SOUTH KOREA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 105 SOUTH KOREA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 106 SOUTH KOREA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 107 SOUTH KOREA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 108 SOUTH KOREA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 109 SOUTH KOREA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 110 SOUTH KOREA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 111 SOUTH KOREA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 112 SOUTH KOREA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 113 SOUTH KOREA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 114 SOUTH KOREA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 115 SOUTH KOREA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 116 INDONESIA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 117 INDONESIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 118 INDONESIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 119 INDONESIA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 120 INDONESIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 121 INDONESIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 122 INDONESIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 123 INDONESIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 124 INDONESIA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 125 INDONESIA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 126 INDONESIA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 127 INDONESIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 128 THAILAND RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 129 THAILAND EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 130 THAILAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 131 THAILAND BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 132 THAILAND RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 133 THAILAND RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 134 THAILAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 135 THAILAND INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 136 THAILAND RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 137 THAILAND RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 138 THAILAND RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 139 THAILAND RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 140 SINGAPORE RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 141 SINGAPORE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 142 SINGAPORE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 143 SINGAPORE BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 144 SINGAPORE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 145 SINGAPORE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 146 SINGAPORE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 147 SINGAPORE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 148 SINGAPORE RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 149 SINGAPORE RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 150 SINGAPORE RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 151 SINGAPORE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 152 MALAYSIA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 153 MALAYSIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 154 MALAYSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 155 MALAYSIA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 156 MALAYSIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 157 MALAYSIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 158 MALAYSIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 159 MALAYSIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 160 MALAYSIA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 161 MALAYSIA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 162 MALAYSIA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 163 MALAYSIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 164 PHILIPPINES RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 165 PHILIPPINES EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 166 PHILIPPINES INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 167 PHILIPPINES BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 168 PHILIPPINES RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 169 PHILIPPINES RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 170 PHILIPPINES EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 171 PHILIPPINES INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 172 PHILIPPINES RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 173 PHILIPPINES RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 174 PHILIPPINES RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 175 PHILIPPINES RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 176 REST OF ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
Back to Top